For instance, inhibition of MCT4 can impede lactate accumulation in the tumor microenvironment (TME) and augment CD8+ T cell-mediated anti-tumor immune response in hepatocellular carcinoma (HCC) (208). Here, CD8A is linked to neoplasm.